160 related articles for article (PubMed ID: 1617638)
1. Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Ciocca DR; Fuqua SA; Lock-Lim S; Toft DO; Welch WJ; McGuire WL
Cancer Res; 1992 Jul; 52(13):3648-54. PubMed ID: 1617638
[TBL] [Abstract][Full Text] [Related]
2. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Oesterreich S; Weng CN; Qiu M; Hilsenbeck SG; Osborne CK; Fuqua SA
Cancer Res; 1993 Oct; 53(19):4443-8. PubMed ID: 8402609
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
4. Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.
Huot J; Roy G; Lambert H; Chrétien P; Landry J
Cancer Res; 1991 Oct; 51(19):5245-52. PubMed ID: 1913647
[TBL] [Abstract][Full Text] [Related]
5. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells.
Richards EH; Hickey E; Weber L; Master JR
Cancer Res; 1996 May; 56(10):2446-51. PubMed ID: 8625326
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
7. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells.
Hansen RK; Oesterreich S; Lemieux P; Sarge KD; Fuqua SA
Biochem Biophys Res Commun; 1997 Oct; 239(3):851-6. PubMed ID: 9367858
[TBL] [Abstract][Full Text] [Related]
11. Use of polymerase chain reaction to detect the expression of the Mr 70,000 heat shock genes in control or heat shock leukemic cells as correlated to their heat response.
Mivechi NF; Rossi JJ
Cancer Res; 1990 May; 50(10):2877-84. PubMed ID: 2334891
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 27 plays two distinct roles in controlling human breast cancer cell migration on laminin-5.
Rust W; Kingsley K; Petnicki T; Padmanabhan S; Carper SW; Plopper GE
Mol Cell Biol Res Commun; 1999 Jun; 1(3):196-202. PubMed ID: 10425226
[TBL] [Abstract][Full Text] [Related]
13. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
14. Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).
Ciocca DR; Green S; Elledge RM; Clark GM; Pugh R; Ravdin P; Lew D; Martino S; Osborne CK
Clin Cancer Res; 1998 May; 4(5):1263-6. PubMed ID: 9607585
[TBL] [Abstract][Full Text] [Related]
15. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
[TBL] [Abstract][Full Text] [Related]
16. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.
Garrido C; Ottavi P; Fromentin A; Hammann A; Arrigo AP; Chauffert B; Mehlen P
Cancer Res; 1997 Jul; 57(13):2661-7. PubMed ID: 9205074
[TBL] [Abstract][Full Text] [Related]
17. Specific regulation of HSPs in human tumor cell lines by flavonoids.
Morino M; Tsuzuki T; Ishikawa Y; Shirakami T; Yoshimura M; Kiyosuke Y; Matsunaga K; Yoshikumi C; Saijo N
In Vivo; 1997; 11(3):265-70. PubMed ID: 9239522
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines.
Zanini C; Giribaldi G; Mandili G; Carta F; Crescenzio N; Bisaro B; Doria A; Foglia L; di Montezemolo LC; Timeus F; Turrini F
J Neurochem; 2007 Nov; 103(4):1344-54. PubMed ID: 17680992
[TBL] [Abstract][Full Text] [Related]
20. Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation.
Stammler G; Pommerenke EW; Masanek U; Mattern J; Volm M
J Exp Ther Oncol; 1996 Jan; 1(1):39-48. PubMed ID: 9414387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
